Frank Panzarella named Vice President for Oncology Services at Dartmouth's Dartmouth-Hitchcock's Norris Cotton Cancer Center
Frank Panzarella will join Norris Cotton Cancer Center as the vice president for Oncology Services.
The U.S. Food and Drug Administration (FDA) authorized the use of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised people, with the third dose to be administered at least 28 days following the first two doses.
Prouty community reaches record-breaking fundraising goal for 40th year
Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center Earns National Accreditation from the Commission on Cancer of the American College of Surgeons
Norris Cotton Cancer Center Researchers Discover How a Plant Virus Activates the Immune System Against Cancer
Immunology researchers led by Dartmouth and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) have identified pathways through which cowpea mosaic virus, a plant virus that does not infect mammals, is recognized by the immune system.
Dartmouth-Hitchcock, Geisel School of Medicine, and State, Regional and National Cancer Experts Partner to Present the New Hampshire Childhood Cancer Conference June 10, 2021
Meet DHMC's new Chief Research Officer
Charles R. Thomas, Jr., MD, Named Chief of Radiation Oncology at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center
After an extensive national search, Dartmouth and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) has named Charles R. Thomas, Jr., MD, as the new Chief of the Section of Radiation Oncology
Dartmouth and Dartmouth-Hitchcock Cancer Researchers Discover Cutting-Edge Approach to Fighting a Form of Deadly Cancer
Researchers at Norris Cotton Cancer Center have developed a way to predict chemotherapy response to tailor treatments for pancreatic cancer patients
Norris Cotton Cancer Center and Other Top U.S. Cancer Centers Call for Urgent Action to Get Cancer-Preventing HPV Vaccination Back on Track
Dartmouth’s and D-H's Norris Cotton Cancer Center is partnering with 70 other National Cancer Institute designated cancer centers to issue a joint statement urging the nation’s physicians, parents and young adults to get the HPV vaccination back on track.